A new funding round for the HFA Research Fund is now open.
The HFA Council and Staff wish you a happy and safe festive season. The HFA office will close on Thursday 24 December 2020 and reopen on Monday 11 January 2021.
An update from HFA about the arrangements to access Hemlibra®, a treatment for haemophilia, and HFA’s ongoing work to advocate for new treatments.
We’re excited to kick off Bleeding Disorders Awareness Week today!. This week is an opportunity for individuals and families like you to take part in the campaign and get involved in activities to raise awareness about haemophilia, von Willebrand disease and related inherited bleeding disorders throughout Australia.
The National Blood Authority (NBA) released information today about the arrangements to add emicizumab (Hemlibra®) as a treatment for Australians on the National Product List.
The National Blood Authority (NBA) released information today about the arrangements to add emicizumab (Hemlibra®) as a treatment for Australians on the National Product List.
Emicizumab (Hemlibra®) will be publicy funded as a treatment for Australians with haemophilia
It's R U OK day today.
HFA staff are now working remotely during the current coronavirus crisis. 
 
How much do you know about bleeding disorders in women and girls? Find out in our fun quiz for Women's Health Week 2020.

Join the HFA community

Sign up for the latest news, events and our free National Haemophilia magazine

Skip to content